about
EphA receptor signaling--complexity and emerging themesMelanoma: from mutations to medicineCrucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia.Melanoma: clinical features and genomic insights.Eph receptor tyrosine kinases in cancer stem cellsPredictive biomarkers for dasatinib treatment in melanoma.EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma.Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.Eph receptors and ephrins as targets for cancer therapy.Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state.Eph/ephrin signaling in epidermal differentiation and diseaseEphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal CancerEphA2 silencing promotes growth, migration, and metastasis in salivary adenoid cystic carcinoma: in vitro and in vivo studyInteraction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.Eph receptor signaling and ephrinsSurface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.The Eph/Ephrin family in cancer metastasis: communication at the service of invasion.Therapeutic targeting of EPH receptors and their ligands.Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.Eph receptors and ephrins: therapeutic opportunities.The role of Eph receptors and Ephrins in the skin.EPHA2 Blockade Overcomes Acquired Resistance to EGFR Kinase Inhibitors in Lung Cancer.EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells.Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 ReceptorBAP1 has a survival role in cutaneous melanoma.A conserved Eph family receptor-binding motif on the gH/gL complex of Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus.
P2860
Q26864082-A3038C6D-6BF8-4C5D-9011-1FA80ED5E444Q27024061-E6330257-822C-4309-86EA-374C63C6B1DFQ28115187-43E51C3D-7CCC-48AB-A0F8-E42A632029BAQ34047326-82281E8D-A1F6-49BF-BEAA-7FE293951C0DQ34083191-EBA628C5-48B4-421D-841A-6A2A4C1E0E1FQ34527304-B9CC4A4E-989D-4D19-A0BB-F7A59CCE8C0CQ34781153-EB534475-21F8-4B05-A4DC-271D6C54D180Q35163679-603BA7AD-90E4-473D-AC73-332C48B5F6BFQ35164121-8FAB4891-30F7-41D5-A3E1-6AF73F1D3132Q35370195-B1DCDBF7-0FA6-42D7-AC91-B255B8A11253Q35487251-74C91AF0-1C47-4B3D-9FFD-33A12F19A80DQ36045304-C9CE5FF7-6EC9-4A41-86C3-19D8219A1E53Q36411034-E1AE5D00-55A4-498C-A5CD-DAEE83335B8BQ36878606-2139298F-1CC4-4FA3-8D80-DC293BB61615Q36906240-01735586-2A2F-4BF0-AB36-330BC4B47C4BQ37122330-022E4B58-FC19-45BC-82E7-D3AF0C95CA68Q37235596-61E5305B-6876-41E4-8DAD-A98216BE8340Q37589930-02B0533C-8AFB-44DB-B6C1-3FE91847B9C2Q38006838-4EF4585B-72C7-4B4B-8F4C-97DBE9A414F6Q38174793-AC5A542B-2840-485F-833C-3967ADCC257FQ38209232-0EACFB45-18FE-4A09-813B-D85A7DDF3555Q38257853-EE8C28CD-7CDB-4E2C-89B1-717456EF2E9DQ38615784-F5229A27-822D-43B4-83D0-B9B65019802BQ38805633-9D4A40B3-877C-43A4-9419-8C4B99C5AE6BQ39141664-79950D53-D409-4A5C-9319-52E8BC354178Q39886331-B22F1D78-01AF-4576-921E-C5506A87059EQ41915374-9EC8DD3B-30C2-42C2-88C8-1CF51D3CB33CQ43194421-BD9D960A-39E9-4E3E-B7D4-3E1AE9277E30Q50062340-09DC1731-5A01-4C9A-93A2-64978832D91E
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
EphA2 is a critical oncogene in melanoma.
@ast
EphA2 is a critical oncogene in melanoma.
@en
type
label
EphA2 is a critical oncogene in melanoma.
@ast
EphA2 is a critical oncogene in melanoma.
@en
prefLabel
EphA2 is a critical oncogene in melanoma.
@ast
EphA2 is a critical oncogene in melanoma.
@en
P2093
P2860
P356
P1433
P1476
EphA2 is a critical oncogene in melanoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.210
P407
P577
2011-06-13T00:00:00Z